Contract Manufacturing
.jpg)
AVVA RUS JSC, a private Russian pharmaceutical company, invites international partners for cooperation in contract manufacturing
Certificates or compliance with EU GMP, ISO 9001, ISO 13485
1996 —
established
The manufacturing site of AVVA RUS JSC is located at 53a Luganskaya St., Kirov, Russia, and includes:
Facility for manufacturing of penicillin-like β-lactam antibiotics
Capsules, powders, tablets, coated tablets
.jpg)
Facility for manufacturing of generic drugs
.jpg)
In autumn 2017, the existing quality system and Good Manufacturing Practices at the AVVA RUS plant in Kirov were audited by European state auditors.
In January 2018, AVVA RUS obtained a EU GMP certificate EU GMP certificate to manufacture medicines for human use, thereby confirming the highest quality standard of its products.
The products manufactured at the AVVA RUS production site can be registered and supplied in the Russian Federation, CIS, Mongolia, EU and other countries, which are current members of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) (Portugal, Romania, Cyprus, Chile, Vietnam, etc.)
In January 2018, AVVA RUS obtained a EU GMP certificate EU GMP certificate to manufacture medicines for human use, thereby confirming the highest quality standard of its products.
The products manufactured at the AVVA RUS production site can be registered and supplied in the Russian Federation, CIS, Mongolia, EU and other countries, which are current members of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) (Portugal, Romania, Cyprus, Chile, Vietnam, etc.)
Currently, AVVA RUS is dynamically involved in the implementation of Pharma 2020, a Russian state program.
AVVA RUS has been manufacturing products for more than 25 years
AVVA RUS has been manufacturing products for more than 25 years, and its current portfolio includes about 70 efficient drugs, including both generics (Micrazim, Ecofuril, Ecofucin, Minoleksin, ecoantibiotics etc.) and original medicines developed by the company (Lactofiltrum and Filtrum).
You can get more detailed information about our preparations here The company specializes in the following key areas:
Gastroenterology
Pediatrics
Cardiology
Neurology
Allergology
Infectious diseases
In 2015 AVVA RUS JSC was included into the list of entities with a substantial impact on the industrial sector in Russia by the corresponding act of the Russian Ministry of Industry and Trade.
With its considerable experience in contract works and regulatory support, AVVA RUS JSC is interested in localizing the products of international developers and manufacturers at its facilities and invites potential partners to mutually beneficial high-quality cooperation, including localizing the manufacturing of penicillin-like β-lactam antibiotics.
Why us
We use and apply modern technology
We use modern technological equipment and provide a system of quality and product safety
We effectively use our intellectual potential and carry out knowledge management
We offer long-term mutually beneficial relationships to our partners
Advantages for potential AVVA RUS partners:
- Wide experience in Russian regulatory system
- Wide production capacities
- Status of drugs as medicinal products manufactured in the Russian Federation
- Public procurement sales opportunities with state support for Russian manufacturers
- Broad coverage of the national market, work with large distributors, presence in the pharmacy and inpatient sectors
- Advisory services of qualified health specialists
- Experience in the successful introduction of new brands to the Russian market and a highly professional marketing and sales staff
- Expert knowledge of all major therapeutic areas, including gastroenterology, otolaryngology, dermatology, pediatrics, gynecology and more
- Flexible approach to developing cooperation with partners
Our partners
.png)
.png)
.png)
Do you want to become our partner?
To get a more detailed offer, please complete the feedback form and our specialists will contact you as soon as possible.
